Teva Pharmaceutical Industries Ltd. (TEVA)
36.44
-1.18
(-3.14%)
USD |
NYSE |
Aug 28, 16:00
36.45
+0.01
(+0.03%)
After-Hours: 20:00
Teva Pharmaceutical Industries Gross Profit Margin (Quarterly) : 52.07% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.07% |
| March 31, 2026 | 49.64% |
| December 31, 2025 | 56.49% |
| September 30, 2025 | 51.33% |
| June 30, 2025 | 50.71% |
| March 31, 2025 | 47.88% |
| December 31, 2024 | 49.74% |
| September 30, 2024 | 49.71% |
| June 30, 2024 | 48.58% |
| March 31, 2024 | 46.56% |
| December 31, 2023 | 54.43% |
| September 30, 2023 | 47.78% |
| June 30, 2023 | 46.37% |
| March 31, 2023 | 43.12% |
| December 31, 2022 | 46.40% |
| September 30, 2022 | 45.91% |
| June 30, 2022 | 46.83% |
| March 31, 2022 | 46.65% |
| December 31, 2021 | 49.41% |
| September 30, 2021 | 45.31% |
| June 30, 2021 | 48.10% |
| March 31, 2021 | 46.11% |
| December 31, 2020 | 46.00% |
| September 30, 2020 | 46.57% |
| June 30, 2020 | 45.27% |
| Date | Value |
|---|---|
| March 31, 2020 | 46.73% |
| December 31, 2019 | 43.65% |
| September 30, 2019 | 44.63% |
| June 30, 2019 | 45.32% |
| March 31, 2019 | 44.73% |
| December 31, 2018 | 44.61% |
| September 30, 2018 | 44.62% |
| June 30, 2018 | 43.25% |
| March 31, 2018 | 45.71% |
| December 31, 2017 | 42.07% |
| September 30, 2017 | 47.18% |
| June 30, 2017 | 49.91% |
| March 31, 2017 | 50.25% |
| December 31, 2016 | 52.22% |
| September 30, 2016 | 50.35% |
| June 30, 2016 | 57.11% |
| March 31, 2016 | 58.02% |
| December 31, 2015 | 58.33% |
| September 30, 2015 | 57.43% |
| June 30, 2015 | 58.31% |
| March 31, 2015 | 56.84% |
| December 31, 2014 | 55.85% |
| September 30, 2014 | 55.54% |
| June 30, 2014 | 52.75% |
| March 31, 2014 | 53.95% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Bristol Myers Squibb Co. | 67.95% |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 10.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.23% |
| Return on Assets | 1.75% |
| Return on Invested Capital | 2.84% |
| Profit Margin (Quarterly) | -13.88% |
| Operating Margin (Quarterly) | 3.78% |
| Return on Net Operating Assets | 2.16% |